EurekaMag.com logo
+ Translate

PCR-based detection of Trypanosoma cruzi useful for specific diagnosis of human Chagas' disease


, : PCR-based detection of Trypanosoma cruzi useful for specific diagnosis of human Chagas' disease. Journal of Clinical Microbiology 34(2): 485-486

A 24-kDa (Tc24) Trypanosoma cruzi recombinant antigen has been used in the serodiagnosis of Chagas' disease. A Tc24-based PCR was developed and used for the diagnosis of human Chagas' disease:17 blood samples were collected from children living in an endemic area of Bolivia. All 17 serologically-positive samples were also positive by PCR.

(PDF 0-2 workdays service)

Accession: 002914461

PMID: 8789049

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Alberti Amador, E..; Fachado Carvajales, A..; Montalvo, A.M.; Izquierdo Perez, L.A.; Galindo, L.F.nte., 1998: Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease Proteasa dependiente de cisteina en Trypanosoma cruzi util en el diagnostico de la enfermedad de Chagas. Revista Cubana de Medicina Tropical, 501: 75-81

Santos, F.Luciano.Neves.; Celedon, P.Alejandra.Fiorani.; Zanchin, N.Ivo.Tonin.; Brasil, T.de.Arruda.Campos.; Foti, L.; Souza, W.Vieira.de.; Silva, E.Domingos.; Gomes, Y.de.Miranda.; Krieger, M.Aurélio., 2016: Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease. The performance of serologic tests in chronic Chagas disease diagnosis largely depends on the type and quality of the antigen preparations that are used for detection of anti-Trypanosoma cruzi antibodies. Whole-cell T. cruzi extracts or recombinan...

Ponce, C.; Ponce, E.; Vinelli, E.; Montoya, A.; de Aguilar, V.; Gonzalez, A.; Zingales, B.; Rangel-Aldao, R.; Levin, M.J.; Esfandiari, J.; Umezawa, E.S.; Luquetti, A.O.; da Silveira, Jé.Franco., 2005: Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. In this study we compared the performance of the Chagas Stat-Pak rapid immunochromatographic test with a standard enzyme-linked immunosorbent assay (ELISA) in the serodiagnosis of Chagas' disease in Central America. Out of 3,400 blood donor s...

Pan, A.A.; Rosenberg, G.B.; Hurley, M.K.; Schock, G.J.; Chu, V.P.; Aiyappa, A., 1992: Clinical evaluation of an EIA for the sensitive and specific detection of serum antibody to Trypanosoma cruzi (Chagas' disease). A commercial EIA for the detection of antibody to Trypanosoma cruzi was clinically evaluated. The primary use of this test is in the diagnosis and screening of donated blood in Latin America. When compared with sera positive by xenodiagnosis, the...

Pan A.A.; Brashear R.J.; Winkler M.A.; Lee H., 1991: A specific and sensitive enzyme immunoassay and confirmatory test for the detection of antibody to trypanosoma cruzi chagas disease. Transfusion (Bethesda) 31(8 SUPPL): 15S

Nagarkatti, R.; de Araujo, F.Fortes.; Gupta, C.; Debrabant, A., 2014: Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice. Chagas disease affects about 5 million people across the world. The etiological agent, the intracellular parasite Trypanosoma cruzi (T. cruzi), can be diagnosed using microscopy, serology or PCR based assays. However, each of these methods has the...

Schechter, M.; Flint, J.E.; Voller, A.; Guhl, F.; Marinkelle, C.J.; Miles, M.A., 1983: Purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas' disease). Trypanosoma cruzi, purified specific glycoprotein with the enzyme-linked immunosorbent assay useful in differential diagnosis from leishmaniasis, same test used with mouse model to differentiate T. rangeli from T. cruzi: Brazil

Guhl, F., 1990: Purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas' disease). Memorias do Instituto Oswaldo Cruz 85(4): 531-532

Cordeiro, F.D.; Martins Filho, O.A.; Rocha, M.O.C.; Adad, S.J.; Correa Oliveira, R.; Romanha, A.J., 2000: Anti-Trypanosoma cruzi IgG1 can be a useful tool for diagnosis and prognosis of human Chagas disease. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 178

Cordeiro, F.D.; Martins-Filho, O.A.; D.C.sta Rocha, M.O.; Adad, S.J.; Corrêa-Oliveira, R.; Romanha, A.J., 2001: Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Two functionally distinct antibodies, categorized as conventional serology antibodies (CSA) and lytic antibodies (LA) have been described in Chagas' disease, based on their ability to bind to fixed epimastigotes (EPI) or live trypomastigotes...